The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae
The anti-CD20 antibody Rituximab to deplete CD20+ B cells is an effective treatment for rheumatoid arthritis and B cell malignancies, but is associated with an increased incidence of respiratory infections. Using mouse models we have investigated the consequences of B cell depletion on natural and a...
Main Authors: | Giuseppe Ercoli, Elisa Ramos-Sevillano, Rie Nakajima, Rafael Ramiro de Assis, Algis Jasinskas, David Goldblatt, Philip Felgner, Gisbert Weckbecker, Jeremy Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.611661/full |
Similar Items
-
Maintained partial protection against Streptococcus pneumoniae despite B‐cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine
by: Giuseppe Ercoli, et al.
Published: (2022-01-01) -
Mechanisms of Naturally Acquired Immunity to Streptococcus pneumoniae
by: Elisa Ramos-Sevillano, et al.
Published: (2019-03-01) -
Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease
by: Yashuan eChao, et al.
Published: (2015-01-01) -
Protective Effect of Nasal Colonisation with <i>∆cps/piaA</i> and <i>∆cps/proABC</i><i>Streptococcus pneumoniae</i> Strains against Recolonisation and Invasive Infection
by: Elisa Ramos-Sevillano, et al.
Published: (2021-03-01) -
Characterization of the Competitive Pneumocin Peptides of Streptococcus pneumoniae
by: Wei-Yun Wholey, et al.
Published: (2019-03-01)